Mustafa Elshani

5PUBLICATIONS
29CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Health and ecological risk assessmentPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 08, 2023
Transcription Factor NFE2L1 Decreases in Glomerulonephropathies after Podocyte Damage.

Mustafa Elshani, In Hwa Um, Steve Leung

|Sep 09, 2021
The Novel Nucleoside Analogue ProTide NUC-7738 Overcomes Cancer Resistance Mechanisms In Vitro and in a First-In-Human Phase I Clinical Trial.

Hagen Schwenzer, Erica De Zan, Mustafa Elshani

|Nov 20, 2020
Tissue-Specific Immunopathology in Fatal COVID-19.

David A Dorward, Clark D Russell, In Hwa Um

Pageof 1